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Abstract
Recent advances in genomics provide genetic information from humans and other
mammals (mouse, rat, dog and primates) traditionally used as models as well
as new candidates (pigs and cattle). In addition, linked enabling technologies,
such as transgenesis and animal cloning, provide innovative ways to design and
perform experiments to dissect complex biological systems. Exploitation of genomic
information overcomes the traditional need to choose naturally occurring models.
Thus, investigators can utilize emerging genomic knowledge and tools to create
relevant animal models. This approach is referred to as reverse genetics. In contrast
to ‘forward genetics’, in which gene(s) responsible for a particular phenotype
are identiﬁed by positional cloning (phenotype to genotype), the ‘reverse genetics’
approach determines the function of a gene and predicts the phenotype of a
cell, tissue, or organism (genotype to phenotype). The convergence of classical
and reverse genetics, along with genomics, provides a working deﬁnition of a
‘genetic model’ organism (3). The recent construction of phenotypic maps deﬁning
quantitative trait loci (QTL) in various domesticated species provides insights into
how allelic variations contribute to phenotypic diversity. Targeted chromosomal
regions are characterized by the construction of bacterial artiﬁcial chromosome
(BAC) contigs to isolate and characterize genes contributing towards phenotypic
variation. Recombineering provides a powerful methodology to harvest genetic
information responsible for phenotype. Linking recombineering with gene-targeted
homologous recombination, coupled with nuclear transfer (NT) technology can
provide ‘clones’ of genetically modiﬁed animals. Copyright  2004 John Wiley &
Sons, Ltd.
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Introduction
Comparative genomics provides an important cri-
terion for creating animal models relevant to dis-
secting human diseases. Resolving complex human
diseases is difﬁcult (e.g. time course of dis-
ease onset in animals, expenses associated with
human clinical experiments, ethical issues), and
thus appropriate biomedical models must be devel-
oped and validated. Biomedical models are deﬁned
as ‘surrogates for a human being, or a human bio-
logic system, that can be used to understand nor-
mal and abnormal function from gene to phenotype
and to provide a basis for preventive or therapeu-
tic intervention in human diseases’ [10,18]. In the
past, researchers have used two main approaches
to study human diseases. In one strategy, a human
clinical disease is fully characterized and then the
most appropriate animal model is chosen, based
on criteria such as anatomical and/or physiological
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characteristics (biological relevance), cost and ani-
mal husbandry required. Another tactic has been
to characterize naturally occurring or induced (by
chemical or radiation exposure) mutant animals
(most commonly the rat or mouse) and identify
which human disease they resemble.
Integrating gene discovery and functional analy-
sis is key to harvesting the ‘genomic promise’. Val-
idation of identiﬁed genes associated with QTL is
essential. Because traditional validation approaches
are time consuming, expensive and complicated
by the diverse genetic backgrounds of non-inbred
breeding stock, new methods of directly testing the
causal effect of a given gene for a given phenotype
are required. Because complex traits are polygenic
(i.e. controlled by more than one genetic compo-
nent), the ability to use a somatic cell target prior
to NT to produce multiple gene substitutions into a
single genetic background is essential for validat-
ing genetic interactions. Finally, by using somatic
cell genomics, an ex vivo platform for expression
proﬁling prior to NT, the number and associated
costs of transgenic animals may be reduced.
Over the past decade, tremendous progress has
been made with regard to the mapping and char-
acterization of the swine genome. Moderate- to
high-resolution genetic linkage maps containing
highly polymorphic loci (Type II) have been
produced using independent mapping populations
[11,15]. Additionally, physical mapping methods,
such as somatic cell hybrid analysis [12,19],
in situ hybridization and ZOO-FISH [1] have been
employed to enrich the Type I marker map and
to perform comparative analysis with map-rich
species such as the human and mouse. To date,
over 5000 mapped loci are catalogued for the
pig genome (http://www.thearkdb.org). Swine
whole-genome radiation hybrid (WG-RH) maps
also have been generated [6], resulting in yet
another rapid increase in the number of loci
mapped. Even more recently, the swine genomics
community has acquired access to resources such
as BAC libraries [5] to facilitate the production
of high-resolution physical maps in speciﬁc chro-
mosomal regions [13,14], and the construction of
sequence-ready mapping resources for the porcine
genome.
In current model systems (fruit ﬂy, yeast, round-
worm and mouse), functional genomics is sup-
ported by the ability to develop congenic inbred
lines, cloning and creating mutants by either dele-
tion or substitution of speciﬁc genes [17]. In pigs
and cattle, there are neither inbred lines nor embry-
onic stem cell (ES) lines to create gain-of-function
(GOF, knock-in) or loss-of-function (LOF, knock-
out) lines. In addition, the relatively long gestation
time and costs of creating large breeding herds to
map polygenic traits devoid of various background
genes is not cost-effective with respect to validating
QTL through breeding. Thus, there is an important
need to develop in vitro correlates for transcrip-
tion proﬁling (functional genomics and proteomics)
similar to that developed for the worm, ﬂy and
mouse. This discovery platform must also allow
capture of sequence information from compara-
tive genomes (creating models to validate hypothe-
ses with respect to gene–gene interactions asso-
ciated with multigenic traits). It is also important
that such an experimental system should allow the
introgression of ‘alleles’ into germplasm, overcom-
ing the current limitation of complicated targeting
and deletion constructs and manipulation involved
in constructing large pieces of DNA for homol-
ogous recombination (HR). Such a model for an
integrated approach to build, test and reﬁne cellu-
lar pathways resulting from speciﬁc perturbations
(analysed by DNA microarrays) has recently been
developed using Saccharomyces cerevisiae [17].
‘Recombineering’, or ‘chromosomal engineer-
ing’, permits directed genetic modiﬁcation of
genomic DNA and links gene discovery of a given
phenotype with functional analysis (directly test-
ing cause and effect) [2]. Recombineering provides
a rapid method to genetically manipulate large
DNA inserts cloned into BACs [16]. BACs have
proved useful for cloning and maintenance of large
DNA fragments in a recA− genetic background
that prevents genomic rearrangement. However,
such host backgrounds also prevent the manipula-
tion of insert DNA using conventional homologous
recombination techniques [9]. Recently, a number
of approaches involving modiﬁcation of the host
bacterium have been developed to permit BAC
manipulation. These have included inducible pro-
moters to permit transient expression of bacterial
recE and recT genes or other analogous bacte-
riophage lambda (λ) genes (exo and beta) [20].
Recently an Escherichia coli strain harbouring a
defective λ-prophage has been developed that pro-
motes high BAC recombination frequencies.
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In order to make this system suitable for BAC
manipulation, the E. coli strain DY380 was gener-
ated by introducing the λ prophage into the BAC
host strain DH10B [16]. The λ prophage provides a
rapid single-step method to generate subtle changes
in any gene in BAC clones using oligonucleotides
as targeting vectors. By using a PCR-based selec-
tive ampliﬁcation screen to identify targeted clones,
this system enables the generation of single-base
changes, deletions (up to 1.93 kb), and the insertion
of unique sequences in different regions of a BAC
containing Brca2. This system has since been used
to generate BAC transgenic mice using a Brca2-
deﬁcient genetic background [7]. In addition, the
ability to insert the fusion tag FLAG, that consists
of eight amino acids, including an enterokinase-
cleavage site [4], into the Brca2 gene provided a
unique method to monitor gene expression.
In order for this experimental approach to be
successful, DNA sequence information of rele-
vant genomic regions containing genes of interest
must be accessible. In our laboratory, we have tar-
geted genomic sequencing of chromosomal regions
that either contribute to resolving complex pheno-
types (QTL) or act as biomedical research mod-
els. Regions of interest include the porcine MHC
class I, myostatin, neuroﬁbromatosis (NF-1) and
the ataxia-telangiectasia (AT) genes. In this review,
we describe how we have utilized the porcine BAC
403O5 (from the RPCI-44 library) that contains the
myostatin gene to demonstrate our ability to intro-
duce small and large insertions and to monitor the
expression of recombineered genes in transfected
ﬁbroblasts.
Genetic modiﬁcations of BACs
Using the recombinogenic E. coli strain DY380,
we have rapidly generated multiple genetic mod-
iﬁcations in BAC clones, harbouring the porcine
myostatin gene [13]. PCR-derived ssDNA frag-
ments were used to delete a 68 bp fragment from
exon 3 of the porcine myostatin gene. A deletion
in this region disrupts gene expression and blocks
synthesis of the myostatin protein, resulting in a
double-muscling phenotype. In order to create a
targeted deletion, a 140 bp ssDNA targeting vector
was constructed using a 100 bp synthetic template
(50 bp ﬂanking the deletion site in both directions)
and 40 bp oligo 5  and 3  primers each of 20 bp
ﬂanking the 100 bp template and 20 bp overlap-
ping the template. In the ﬁrst set of experiments
we used PCR screening with primers, designed
using BAC sequencing information, ﬂanking the
deletion site of the gene. Upon analysis follow-
ing recombineering, we identiﬁed PCR pools hav-
ing both wild-type and recombineered product and
demonstrated a recombineering deletion efﬁciency
of 1 recombinant/470 electroporated cells. This is
a lower targeting efﬁciency than was obtained in
a similar experiment by Swaminathan et al. [16],
where they introduced a deletion into exon 11 of
the murine Brca2 gene with a 1/120 targeting fre-
quency. Thus, we re-screened our pools using the
mismatch ampliﬁcation mutation assay (MAMA-
PCR) and the annealing temperature was adjusted
so that a PCR product would only be ampliﬁed
from BACs having a deletion, whereas a wild-type
BAC would not be ampliﬁed. This approach per-
mitted the detection of 1 recombinant/170 electro-
porated cells. DNA sequencing of the recombinant
clones conﬁrmed that the targeted deletion occurred
in the desired location.
Recombineering inserts into porcine BACs
The ability to generate small insertions is a key
step in using the recombineering methodology to
develop an animal model. Experiments were there-
fore designed to determine the targeting precision
of inserting speciﬁc short sequences into a particu-
lar BAC region. The 24 bp sequence encoding the
FLAG octapeptide, which when attached to the
C-terminus of a protein can be used as a tag to dis-
tinguish between normal and modiﬁed protein and
monitor protein movement within a cell as well
as for protein puriﬁcation by afﬁnity chromatogra-
phy, was utilized [13]. An oligonucleotide targeting
vector (164 bp) to attach the FLAG tag at the
C-terminus of myostatin was synthesized by PCR
using two synthetic 94 bp oligonucleotides, which
served as template and primer simultaneously. The
targeting vector thus had 70 bp arms homologous
to target regions ﬂanking both the 5  and 3  end of
the insertion site in the BAC encoding myostatin,
a n dt h e2 4b pF L A G  sequence. The recombi-
nants were identiﬁed in cultured pools and then as
individual colonies by FLAG-speciﬁc PCR, with
a 1/260 targeting efﬁciency. DNA sequencing of
three PCR-positive individual clones showed that
the targeting was speciﬁc and that no mutations
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were induced in sequences ﬂanking the insertion
site (500 bp in both directions).
Recombineered target expression in somatic
cells
Another vital component in developing a recom-
bineering platform is the ability to use the recom-
bineered BACs to introduce targeted changes in
ﬁbroblast and other somatic cells. These studies
were designed to demonstrate (a) that larger, com-
plex gene constructs could be developed and
(b) that transient gene expression could be mon-
itored following BAC transfection into somatic
cells. This approach requires either a selection
marker such as an antibiotic resistance gene or
another selective marker such as green ﬂuorescent
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Figure 1. (a) Constructing a targeting vector for EGFP insertion. The targeting vector was constructed using 70 bp
arms homologous to sequences upstream and downstream of the insertion site (within exon 3 of the porcine myostatin
gene). The pEGFP-N1 vector (Clontech) was used to amplify the targeting cassette containing the human cytomegalovirus
immediate early promoter. The resulting recombineered vector was PCR-ampliﬁed and then treated with DpnI. The DpnI
restriction enzyme cleaves the methylated GATC DNA of the pEGFP-N1 vector, thus preventing contamination with the
EGFP expression vector in the recombineered preparation. As illustrated, the targeting vector used for recombineering
is approximately 1.7 kb. (b) EGFP gene expression monitored by ﬂow analysis of transfected porcine fetal ﬁbroblasts.
The targeting vector was used to insert EGFP into the myostatin containing BAC (175 kb). E. coli DY380 clones
containing the modiﬁed myostatin–EGFP (recombineered BACs) were grown overnight and BAC DNA was extracted
using a Nucleobond AX kit. Porcine fetal ﬁbroblasts (8HY17F) were then electroporated with BAC DNA (10 µg).
Electroporations using different conditions for EGFP expression were used to establish the amount of BAC and the optimal
time of expression. Thus, cells were grown for 3 days and then sorted by ﬂow cytometry to estimate the percentage of
cells transfected and the level of transient gene expression
protein. We have chosen the enhanced green ﬂu-
orescent protein (EGFP) as a selection marker
(Figure 1a). During the screening of transfected
mammalian cells, EGFP expression can be used
in conjunction with ﬂow cytometric cell sorting
to select for homologous recombinants. Using a
vector containing the EGFP and its promoter and
without a polyA tail, we constructed a 1592 bp
sequence coding for EGFP. A 1772 bp targeting
vector was ampliﬁed from the plasmid pEGFP-N1
(Clontech) using 90 bp PCR primers. Speciﬁc PCR
ampliﬁcation using pooled cells was able to detect
recombinants in 4/190 pools, yielding a targeting
efﬁciency for the large targeting cassette (EGFP)
of 1/775. Although a higher targeting efﬁciency is
observed for small oligonucleotide cassettes (dele-
tion and FLAG), it is still promising that such
a large insert could be incorporated in a single
step without the requirement of additional antibi-
otic resistance or other selection markers.
The recombineered BAC (EGFP–myostatin
fusion gene) was then used to transfect fetal porcine
ﬁbroblasts to demonstrate the ability of recom-
bineered genes to be expressed. As shown in
Figure 1b, we were able to demonstrate the expres-
sion of EGFP by fetal ﬁbroblasts as measured by
ﬂow cytometry. This study showed the efﬁciency
of transient expression of recombineered myostatin
BAC (approximately 170 kb) to be around 0.01%,
which is consistent with previous studies [8]. These
results suggest that insertions longer than 1000 bp
can be successfully recombineered into a gene
of interest. Constructs generated by this approach
could also be used to develop speciﬁcally modiﬁed
somatic cells for conditional expression, GOF or
LOF studies.
Discussion
This review summarizes our development of a
somatic cell technology platform that integrates the
recombineering of genomic DNA with the subse-
quent targeted gene manipulation of somatic cell
lines. This platform provides a novel approach
for dissecting physiological pathways using deﬁned
genetic systems in vitro while avoiding the cost
of validation in non-inbred animals and ‘genetic
noise’ from various background genes. The use of
gene-targeted ﬁbroblasts provides a suitable nuclear
donor for use in nuclear transfer to generate unique
swine germplasm for generating biomedical mod-
els. The targeting efﬁciencies observed in this study
for FLAG insertion and deletions are comparable
to those observed using a mouse model [7,16]. Our
attention is now focused on developing site-speciﬁc
recombination systems to permit targeted allelic
substitution in porcine BACs. This will permit us to
target gene function in somatic ﬁbroblast lines and
evaluate downstream events prior to in vivo stud-
ies. As previously reported by Montigny et al.[ 8 ] ,
we were able to demonstrate that BAC DNA purity
and concentration did affect transfection efﬁciency.
Furthermore, although the BAC construct used here
was extremely large (>175 kb), we were able to
demonstrate transfection and expression proﬁles
consistent with other studies [8].
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